• Home
  • PHILOSOPHY
  • Portfolio
  • Team
  • Blog
  • Home
  • PHILOSOPHY
  • Portfolio
  • Team
  • Blog
VIEW ALL
< PREV
NEXT >
Picture
Picture
Tetra is committed to building a leading portfolio of clinical trial stage treatments, based on phosphodiesterase sub-type inhibitors for both neuroscience and non-neuroscience disorders. These are fields in which we believe Tetra is poised to deliver multiple novel treatments, with the potential to change patients’ lives.
SOCIAL MEDIA: 
Website: http://tetradiscovery.com/
Facebook: https://www.facebook.com/tetradiscovery/
Twitter: https://twitter.com/TetradDiscovery
LinkedIn: https://www.linkedin.com/company-beta/1617309/
LOCATION:
38 Fulton St W Ste 303 Grand Rapids, MI  49503
PEOPLE:
CEO: Dr. Mike E. Gurney PHD, MBA 
VP: Mr. Richard M. Erwin

IN THE NEWS

March 26, 2016
Picture
Alzheimer's drugs pipeline therapeutics review H1 2017 published by leading research firm
November 29, 2016
Picture
Tetra Discovery Partners Raises $10 Million through Series A Financing and Two National Institutes of Health Grants
December 19, 2016
Picture
Tetra Discovery Partners Announces Positive Results from Phase 1 Studies of Cognition Drug Candidate, BPN14770
January 17, 2017
Picture
Tetra Discovery Partners Appoints Richard Erwin as Vice President, Clinical Operations
Picture

HOME

PHILOSOPHY

PORTFOLIO

TEAM

BLOG

Copyright © 2017 Trout Creek Ventures. All Rights Reserved.​
  • Home
  • PHILOSOPHY
  • Portfolio
  • Team
  • Blog